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Abstract
Objective: Besides angiotensin converting enzyme 2 (ACE2), an active involvement
of proteases (FURIN and/or TMPRSS2) is important for cellular entry of SARS-
CoV-2. Therefore, a simultaneous expression profiling of entry proteins in a tissue
might provide a better risk assessment of SARS-CoV-2 infection as compared to indi-
vidual proteins. In an attempt to understand the relative susceptibility of oral squa-
mous cell carcinoma (OSCC) lesions as compared to the normal oral mucosa (NOM)
for SARS-CoV-2 attachment/entry, this study examined the mRNA and protein
expression profiles of ACE2, FURIN, and TMPRSS2 in the corresponding tissues
using public transcriptomic and proteomics datasets.
Methods and methods: Public transcriptomic and proteomics datasets (the Cancer
Genome Atlas (TCGA)/the Genotype-Tissue Expression (GTEx), the Human Protein
Atlas (HPA), and two independent microarray datasets) were used to examine the
expression profiles of ACE2, TMPRSS2 and FURIN in NOM and OSCC.
Results: ACE2, TMPRSS2, and FURIN mRNAs were detected in NOM, however, at
lower levels as compared to other body tissues. Except for moderate up-regulation
of FURIN, expression levels of ACE2 and TMPRSS2 mRNA were unchanged/down-
regulated in OSCC as compared to the NOM.
Conclusions: These results indicate that NOM may serve as a possible site for SARS-
CoV-2 attachment, however, to a lesser extent as compared to organs with higher
expression levels of the SARS-CoV-2 entry proteins. However, the evidence is lac-
king to suggest that expression status of entry proteins predisposes OSCC lesions to
additional risk for SARS-CoV-2 attachment/entry as compared to NOM.
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1 | INTRODUCTION
The 2019 novel coronavirus disease (COVID-19) was determined to
be caused by a RNA virus, the SARS-CoV-2 (Zhou et al., 2020). SARS-
CoV-2 infection, at the cellular level, depends on the relative abun-
dance of surface proteins involved in cellular attachment and entry of
SARS-CoV-2 into the host cells. The spike (S) protein, one of the
structural proteins encoded by the viral genome, is important for the
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attachment of virus to the host cells. SARS-CoV-2 cellular entry has
been suggested to be mediated by binding of receptor binding domain
(RBD) of the S protein to a cell surface receptor called angiotensin
converting enzyme 2 (ACE2) (Zhou et al., 2020). It has been shown
that the RBD, although it possesses a high affinity to ACE2, is in fact
less accessible to ACE2 binding as compared to the SARS-CoV RBD,
thereby requiring selective cleavage (priming) of the S protein by cell
surface proteases (co-receptors) for successful cellular entry (Shang
et al., 2020). FURIN (encoded by FURIN gene) is involved in pre-
priming of S protein, thereby facilitating binding of the preactivated S
protein with ACE2 (Hoffmann, Kleine-Weber, & Pöhlmann, 2020;
Shang et al., 2020). On the other hand, TMPRSS2 mediates priming of
ACE2 bound S-protein, thereby promoting viral fusion with the host
cell membrane (Hoffmann, Kleine-Weber, Schroeder, et al., 2020).
Interestingly, pre-priming by FURIN and post-priming by TMPRSS2
proteases have been shown to have a cumulative effect in promoting
SARS-CoV-2 cellular entry (Shang et al., 2020). The dependency of
ACE2 on FURIN and/or TMPRSS2-mediated priming of the S protein
might imply that even a relatively high expression of ACE2 does not
always guarantee a successful SARS-CoV-2 cellular entry if the
expression levels of FURIN and TMPRSS2 are lower or vice-versa.
Hence, a simultaneous expression profiling of ACE2, FURIN, and
TMPRSS2 is expected to provide a better risk assessment of SARS-
CoV-2 attachment on a tissue as compared to the expression status
of individual proteins.
Given the key roles of ACE2, FURIN and TMPRSS2 in SARS-
CoV-2 attachment and cellular entry, tissues with relatively high basal
expression of these proteins such as the lung, heart, esophagus, and
kidney have been suggested to be high-risk host tissues for COVID-
19 (Xin Zou et al., 2020). Moreover, it is reasonable to suspect that
de-regulation of these proteins, a frequent observation in human
malignancies (Kong et al., 2020), might influence the risk of SARS-
CoV-2 infection in these lesions as compared to the normal tissues.
Based on the ACE2 mRNA expression in normal/para-tumor oral epi-
thelium, oral cavity was suggested to be a potential site for SARS-
CoV-2 attachment (Xu et al., 2020). Similarly, a possible link between
oral squamous cell carcinoma (OSCC) and SARS-CoV-2 infection was
previously hypothesized (Chauhan et al., 2020). However, the expres-
sion profiles of ACE2, TMPRSS2 and FURIN have not been compre-
hensively examined in normal oral mucosa (NOM) and OSCC, a major
subgroup of head and neck squamous cell carcinoma (HNSCC). In an
attempt to understand the relative susceptibility of NOM and OSCC
lesions for SARS-CoV-2 attachment, this study examined the mRNA
and protein expression profiles of ACE2, FURIN, and TMPRSS2 in the
corresponding tissues using public transcriptomic and proteomics
datasets.
2 | MATERIALS AND METHODS
Ethical approval and patient consent was not applicable to the cur-
rent study, as only the public databases have been used for the
analysis.
2.1 | Transcriptomic datasets
Transcriptomic datasets were obtained from the Cancer Genome
Atlas (TCGA)/the Genotype-Tissue Expression (GTEx) (GTEx, 2015),
consensus datasets from the Human Protein Atlas (HPA) (Uhlén
et al., 2015), and microarray datasets (Chen et al., 2008; Rentoft
et al., 2012). The Consensus mRNA dataset, generated from a combi-
nation of three datasets (the HPA RNA-seq data, GTEx RNA-seq data
[https://www.gtexportal.org/home/], and FANTOM5: the Functional
Annotation of Mammalian Genomes 5 data) (Forrest et al., 2014),
were obtained from the HPA. The specimen characteristics of differ-
ent transcriptomic datasets were as follows: the HPA dataset con-
sisted of 483 tissue samples representing 37 different human normal
tissues (no oral tissue included), the GTEx consisted of 54 different
human tissues across nearly 1000 individuals (no oral tissue included),
and the FANTOM5 consisted of specimens from 60 different normal
tissues including two tongue specimens. The Consensus mRNA
dataset was used to examine the relative mRNA expression levels of
ACE2, FURIN, and TMPRSS2 in different normal tissues in the body,
including the oral cavity. Using the “box plot” tool in GEPIA (Tang
et al., 2017), the transcriptomic data from TCGA/GTEx (GTEx, 2015)
was used to examine the mRNA levels of ACE2, FURIN, and TMPRSS2
in HNSCC (n = 519) as compared to the normal/para-tumor control
tissues (n = 44). The TCGA/GTEx data in HNSCC were validated
using two independent OSCC microarray datasets: Rentoft
et al. (2012) consisting of 62 OSCC and 16 NOM, and Chen
et al. (2008) consisting of 167 OSCC, 17 oral dysplastic (premalignant
oral lesions) lesions and 45 normal oral controls.
2.2 | Protein datasets
The protein data were obtained from “Protein Expression Overview”
tool from the HPA (Uhlén et al., 2015). These data consisted of speci-
mens from 144 individuals corresponding to 44 different normal tis-
sues, with each normal tissue represented by at least three samples.
Each bar in the “Protein Expression Overview” tool represents the
average intensity of immunohistochemical images for a specific pro-
tein across normal tissues.
3 | RESULTS
3.1 | mRNA and protein expression levels of ACE2,
TMPRSS2, and FURIN in NOM
Using the TCGA, the FANTOM5 CAGE, and in-house data, a previous
study reported a relatively high expression of ACE2 mRNA in normal/
para-tumor oral mucosa (Xu et al., 2020). To further explore the
mRNA and protein expression levels of ACE2, TMPRSS2, and FURIN
in NOM, expression data from the HPA were analyzed in the current
study. The Consensus mRNA dataset from the HPA showed a rela-
tively low (0.05 NX [normalized expression]) ACE2 mRNA expression
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in normal tongue as compared to the other organs such as small intes-
tine, colon, and kidney (Figure 1a). However, according to the HPA,
no ACE2 protein was immunohistochemically detected in NOM
(Figure 1b,c). The mRNA levels of TMPRSS2 (3.9 NX) and FURIN (5.5
NX), although higher than that of ACE2 (Figure 1d,g) in the normal
tongue, were found to be markedly lower than in other normal body
tissues. The corresponding protein levels, according to the HPA, were,
however, undetectable in NOM (Figure 1e,f,h,i).
3.2 | mRNA expression levels of ACE2, TMPRSS2,
and FURIN in OSCC/HNSCC as compared to the
normal controls
Analysis of the TCGA/GTEx data consisting of 519 HNSCC and
44 normal/para-tumor controls showed that ACE2 mRNA expression
in HNSCC was similar to that of the control tissues (Figure 2a). Among
the proteases involved in ACE2 mediated viral entry, TMPRSS2 was
significantly (p < 0.05) down-regulated (Figure 2b), whereas FURIN
(Figure 2c) appeared marginally up-regulated in HNSCC but it was not
statistically significant. Although OSCC represents one of most com-
mon HNSCC types, a heterogeneous group of malignancies from
other areas in the head and neck are also included in HNSCC. Hence,
it is important to validate the HNSCC results using datasets consisting
of only OSCC. Indeed, a similar expression pattern was found for all
of the genes examined in two independent OSCC microarray datasets
(Figure 2d–i). Interestingly, expression profiles of the entry proteins in
oral dysplastic lesions (premalignant oral lesions) were similar to that
of OSCC (Figure 2d–f).
4 | DISCUSSION
The efficiency of the coronavirus cellular entry is key for successful
viral infection and pathogenesis (Perlman & Netland, 2009). The
SARS-CoV-2 cellular entry in turn depends on the relative abundance
of surface proteins ACE2, FURIN, and TMPRSS2. A recent study
reported the presence of ACE2 mRNA in normal/para-tumor oral
mucosa, especially in the TCGA dataset (Xu et al., 2020). In line with
this, ACE2 mRNA was found to be expressed in the tongue
(Figure 1a), although the abundance was markedly lower as compared
to other body tissues such as small intestine, colon, and kidney. The
mRNA expression levels of TMPRSS2 and FURIN were found to be
slightly higher than that of ACE2 in the tongue (Figure 1d,g). Of note,
none of the entry proteins were immunohistochemically detected in
NOM in the HPA dataset (Figure 1b,c,e,f,h,i). A lower sensitivity of
immunohistochemistry as compared to the transcriptome analysis
through RNA-seq could be one of the explanations for this disagree-
ment. In addition, the use of separate sample sets for RNA-seq and
immunohistochemistry could contribute to this discrepancy. Indeed, a
similar discordance between the transcriptomic and immunohisto-
chemistry data was reported for ACE2 and TMPRSS2 in salivary
glands when using public datasets (Pascolo et al., 2020). Nevertheless,
immunohistochemical expression of ACE2 (Hamming et al., 2004) and
FURIN (de Cicco et al., 2004) was previously reported in oral mucosa.
Overall, in the line with previous suggestion (Xu et al., 2020), these
results indicate that oral epithelium can be a possible site for SARS-
CoV-2 attachment. However, the relatively low expression levels of
all entry proteins in NOM as compared to the other body tissues sug-
gest that the risk for SARS-CoV-2 attachment/entry in NOM might
be lower than previously suggested. The suggestion that oral cavity
can be a likely site for SARS-CoV-2 attachment has clinical implica-
tions, as almost all procedures related to the dental examination and
treatment involve close contact with saliva or salivary droplets/aero-
sols. Hence, it is important to follow proper hygienic measures to min-
imize salivary aerosol production and to use appropriate protective
equipment to protect dental personnel from SARS-CoV-2.
Cancer patients, including OSCC are considered one of the high-
risk groups for COVID-19 (Tian et al., 2020; Yu et al., 2020). Older
age, immunocompromised status, existing comorbidities, and frequent
hospital visits have been suggested be some of the factors
predisposing cancer patients for SARS-CoV-2 infection with severe
symptoms and high mortality rate (Lee et al., 2020; Yu et al., 2020).
Besides these systemic/nosocomial factors, there is a growing specu-
lation that overexpression of SARS-CoV-2 cellular entry proteins
might contribute to amplify the risk of viral attachment in lung cancer
lesions (Kong et al., 2020). The unchanged/down-regulated expres-
sion levels of ACE2 and TMPRSS2 in HNSCC/OSCC indicate that their
expression profiles are unlikely to confer increased risk for SARS-
CoV-2 attachment/entry in these lesions as compared to the normal
tissues. In addition, the upregulation of FURIN in HNSCC/OSCC in the
background of unchanged ACE2 mRNA is less likely to amplify the risk
for SARS-CoV-2 attachment, as the pre-primed S-protein requires
ACE2 binding for the cellular entry (Shang et al., 2020). It was inter-
esting to note that expression profiles of entry proteins in oral dys-
plastic (premalignant oral lesions) lesions were similar to that of
OSCC, suggesting that both oral premalignant lesions and OSCC dis-
play similar risk status for virus attachment. Taken together, the evi-
dence is lacking to suggest that the expression status of entry
proteins predisposes OSCC/oral premalignant lesions to additional
risk for SARS-CoV-2 attachment/entry as compared to NOS.
The current study benefited from the use of protein data for NOM
from the HPA, and validation of the TCGA/GTEx HNSCC data by two
independent microarray datasets consisting of OSCC and normal controls
from the oral cavity. The latter is especially important as HNSCC repre-
sents a heterogeneous group of malignancies not only from the oral cavity
but also from the other regions in the head and neck. Additionally, control
tissues in the TCGA/GTEx data mostly represent the para-tumor tissues,
and they might harbor molecular alterations (Aran et al., 2017). However,
the current study also has limitations. The transcriptomic data (the
FANTOM5) and proteomic data (the HPA) for NOM respectively repre-
sent only two and three specimens, and the protein data is lacking for the
OSCC specimens. Future expression studies using a relatively large num-
ber of OSCC/control specimens, together with functional studies focusing
on the entry mechanism of SARS-CoV-2 in OSCC cells are necessary to
clarify the susceptibility of cancer cells to SARS-CoV-2 infection.
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F IGURE 1 Relative mRNA and protein expression levels of ACE2, TMPRSS2, and FURIN in various normal tissues in the body. The mRNA
expression data (a, d, and g) represent the Consensus mRNA dataset obtained from the Human Protein Atlas (HPA). NX, normalized expression.
The red arrows indicate mRNA expression levels of the examined genes in tongue. The protein data (b, e, and h) represent the intensity of
immunohistochemical images of the proteins examined in different human tissues. The black arrows indicate protein expression levels of the
examined protein in oral mucosa. Representative immunohistochemical images of ACE2 (c), TMPRSS2 (f), and FURIN (i) in normal oral epithelium
from the HPA dataset
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F IGURE 2 Expression profile of
ACE2, FURIN, and TMPRSS2 in head
and neck squamous cell carcinoma/
oral squamous cell carcinoma
(HNSCC/OSCC). (a) Expression level
of ACE2 mRNA was similar both in
HNSCC and control tissues.
TMPRSS2 mRNA expression (b) was
significantly down-regulated in
HNSCC whereas the mRNA
expression level of FURIN (c) was
moderately increased as compared
to the control tissues. Publicly
available transcriptomic datasets
(TCGA/GTEx) were analyzed using
the “box plot” tool analysis in GEPIA
(Tang et al., 2017). HNSCC
(n = 519), normal, normal/para-
tumor control epithelium (n = 44),
ns: non-significant.
(d–i) The HNSCC data were
validated using two independent
OSCC microarray datasets (d–f:
Chen et al., 2008 and g–i: Rentoft
et al., 2012). The OSCC cases
included in the Rentoft et al., 2012
dataset were all from the tongue,
whereas the Chen et al., 2008
dataset consisted of OSCC from
different locations in the oral cavity.
For (d–f), one-way analysis of
variance analysis with Tukey's
multiple comparisons test was used
for statistical analysis using
GraphPad prism version 8.0.1 for
Windows (www.graphpad.com). The
error bars represent mean and
standard error of the mean.
(n = 167), Dysplasia: oral dysplastic
lesions (n = 17), normal, normal
control epithelium (n = 45). For (g–i),
unpaired t test was used for
statistical analysis using GraphPad
prism version 8.0.1 for Windows
(www.graphpad.com). The error bars
represent mean and standard error
of the mean. OSCC (n = 62), normal,
normal control epithelium (n = 16)
SAPKOTA ET AL. 5
DATA AVAILABILITY STATEMENT
The data that support the findings of this study are freely available in
the following public resources: the Cancer Genome Atlas (https://
www.cancer.gov/about-nci/organization/ccg/research/structural-gen
omics/tcga, the Genotype-Tissue Expression (GTEx, https://www.
gtexportal.org/home/) (GTEx, 2015), the Human Protein Atlas
(https://www.proteinatlas.org/) (Uhlén et al., 2015), and two microar-
ray datasets (Chen et al., 2008; Rentoft et al., 2012).
ORCID
Dipak Sapkota https://orcid.org/0000-0003-0061-825X
Tine M. Søland https://orcid.org/0000-0003-1687-3247
Paulo H. Braz-Silva https://orcid.org/0000-0002-1842-9521
REFERENCES
Aran, D., Camarda, R., Odegaard, J., Paik, H., Oskotsky, B., Krings, G.,
Goga, A., Sirota, M., & Butte, A. J. (2017). Comprehensive analysis of
normal adjacent to tumor transcriptomes. Nature Communications,
8(1), 1077. https://doi.org/10.1038/s41467-017-01027-z
Chauhan, A., Ghoshal, S., & Pal, A. (2020). Increased susceptibility of
SARS-CoV2 infection on oral cancer patients; cause and effects: An
hypothesis. Medical Hypotheses, 144, 109987. https://doi.org/10.
1016/j.mehy.2020.109987
Chen, C., Méndez, E., Houck, J., Fan, W., Lohavanichbutr, P., Doody, D.,
Yueh, B., Futran, N. D., Upton, M., Farwell, D. G., Schwartz, S. M., &
Zhao, L. P. (2008). Gene expression profiling identifies genes predictive of
oral squamous cell carcinoma. Cancer Epidemiology Biomarkers & Preven-
tion, 17(8), 2152–2162. https://doi.org/10.1158/1055-9965.Epi-07-2893
de Cicco, R. L., Watson, J. C., Bassi, D. E., Litwin, S., & Klein-Szanto, A. J.
(2004). Simultaneous expression of furin and vascular endothelial
growth factor in human oral tongue squamous cell carcinoma progres-
sion. Clinical Cancer Research, 10(13), 4480–4488. https://doi.org/10.
1158/1078-0432.Ccr-03-0670
Forrest, A. R., Kawaji, H., Rehli, M., Baillie, J. K., de Hoon, M. J.,
Haberle, V., Lassmann, T., Kulakovskiy, I. V., Lizio, M., Itoh, M.,
Andersson, R., Mungall, C. J., Meehan, T. F., Schmeier, S., Bertin, N.,
Jørgensen, M., Dimont, E., Arner, E., Schmidl, C., … Hayashizaki, Y.
(2014). A promoter-level mammalian expression atlas. Nature,
507(7493), 462–470. https://doi.org/10.1038/nature13182
GTEx. (2015). The genotype-tissue expression (GTEx) pilot analysis: Multi-
tissue gene regulation in humans. Science, 348(6235), 648–660.
https://doi.org/10.1126/science.1262110
Hamming, I., Timens, W., Bulthuis, M. L. C., Lely, A. T., Navis, G. J., & van
Goor, H. (2004). Tissue distribution of ACE2 protein, the functional
receptor for SARS coronavirus. A first step in understanding SARS
pathogenesis. The Journal of Pathology, 203(2), 631–637. https://doi.
org/10.1002/path.1570
Hoffmann, M., Kleine-Weber, H., & Pöhlmann, S. (2020). A multibasic
cleavage site in the spike protein of SARS-CoV-2 is essential for infec-
tion of human lung cells. Molecular Cell, 78(4), 779–784.e775. https://
doi.org/10.1016/j.molcel.2020.04.022
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T.,
Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N. H., Nitsche, A.,
Müller, M. A., Drosten, C., & Pöhlmann, S. (2020). SARS-CoV-2 cell
entry depends on ACE2 and TMPRSS2 and is blocked by a clinically
proven protease inhibitor. Cell, 181(2), 271–280.e278. https://doi.org/
10.1016/j.cell.2020.02.052
Kong, Q., Xiang, Z., Wu, Y., Gu, Y., Guo, J., & Geng, F. (2020). Analysis of
the susceptibility of lung cancer patients to SARS-CoV-2 infection.
Molecular Cancer, 19(1), 80. https://doi.org/10.1186/s12943-020-
01209-2
Lee, L. Y. W., Cazier, J. B., Starkey, T., Turnbull, C. D., Kerr, R., &
Middleton, G. (2020). COVID-19 mortality in patients with cancer on
chemotherapy or other anticancer treatments: A prospective cohort
study. The Lancet, 395(10241), 1919–1926. https://doi.org/10.1016/
S0140-6736(20)31173-9
Pascolo, L., Zupin, L., Melato, M., Tricarico, P. M., & Crovella, S. (2020).
TMPRSS2 and ACE2 Coexpression in SARS-CoV-2 salivary glands
infection. Journal of Dental Research, 99(10), 1120–1121. https://doi.
org/10.1177/0022034520933589
Perlman, S., & Netland, J. (2009). Coronaviruses post-SARS: Update on
replication and pathogenesis. Nature Reviews Microbiology, 7(6), 439–
450. https://doi.org/10.1038/nrmicro2147
Rentoft, M., Coates, P. J., Laurell, G., & Nylander, K. (2012). Transcriptional
profiling of formalin fixed paraffin embedded tissue: Pitfalls and rec-
ommendations for identifying biologically relevant changes. PLoS One,
7(4), e35276. https://doi.org/10.1371/journal.pone.0035276
Shang, J., Wan, Y., Luo, C., Ye, G., Geng, Q., Auerbach, A., & Li, F. (2020).
Cell entry mechanisms of SARS-CoV-2. Proceedings of the National
Academy of Sciences of the United States of America, 117(21), 11727–
11734. https://doi.org/10.1073/pnas.2003138117
Tang, Z., Li, C., Kang, B., Gao, G., Li, C., & Zhang, Z. (2017). GEPIA: A web
server for cancer and normal gene expression profiling and interactive
analyses. Nucleic Acids Research, 45(W1), W98–W102. https://doi.
org/10.1093/nar/gkx247
Tian, J., Yuan, X., Xiao, J., Zhong, Q., Yang, C., Liu, B., Cai, Y., Lu, Z.,
Wang, J., Wang, Y., Liu, S., Cheng, B., Wang, J., Zhang, M., Wang, L.,
Niu, S., Yao, Z., Deng, X., Zhou, F., … Wang, Z. (2020). Clinical charac-
teristics and risk factors associated with COVID-19 disease severity in
patients with cancer in Wuhan, China: A multicentre, retrospective,
cohort study. The Lancet Oncology, 21(7), 893–903. https://doi.org/
10.1016/S1470-2045(20)30309-0
Uhlén, M., Fagerberg, L., Hallström, B. M., Lindskog, C., Oksvold, P.,
Mardinoglu, A., Sivertsson, Å., Kampf, C., Sjöstedt, E., Asplund, A.,
Olsson, I. M., Edlund, K., Lundberg, E., Navani, S., Szigyarto, C. A. K.,
Odeberg, J., Djureinovic, D., Takanen, J. O., Hober, S., … Pontén, F.
(2015). Tissue-based map of the human proteome. Science, 347(6220),
1260419. https://doi.org/10.1126/science.1260419
Xin Zou, K. C., Zou, J., Han, P., Hao, J., & Han, Z. (2020). Single-cell RNA-seq
data analysis on the receptor ACE2 expression reveals the potential risk of
different human organs vulnerable to 2019-nCoV infection. Frontiers in
Medicine, 14(2), 185–192. https://doi.org/10.1007/s11684-020-0754-0
Xu, H., Zhong, L., Deng, J., Peng, J., Dan, H., Zeng, X., Li, T., & Chen, Q.
(2020). High expression of ACE2 receptor of 2019-nCoV on the epi-
thelial cells of oral mucosa. International Journal of Oral Science, 12(1),
8. https://doi.org/10.1038/s41368-020-0074-x
Yu, J., Ouyang, W., Chua, M. L. K., & Xie, C. (2020). SARS-CoV-2 transmis-
sion in patients with cancer at a tertiary care hospital in Wuhan,
China. JAMA Oncology, 6(7), 1108–1110. https://doi.org/10.1001/
jamaoncol.2020.0980
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H. R.,
Zhu, Y., Li, B., Huang, C. L., Chen, H. D., Chen, J., Luo, Y., Guo, H.,
Jiang, R. D., Liu, M. Q., Chen, Y., Shen, X. R., Wang, X., … Shi, Z.-L.
(2020). A pneumonia outbreak associated with a new coronavirus of
probable bat origin. Nature, 579(7798), 270–273. https://doi.org/10.
1038/s41586-020-2012-7
How to cite this article: Sapkota, D., Sharma, S., Søland, T. M.,
Braz-Silva, P. H., & Teh, M.-T. (2021). Expression profile of
SARS-CoV-2 cellular entry proteins in normal oral mucosa and
oral squamous cell carcinoma. Clinical and Experimental Dental
Research, 1–6. https://doi.org/10.1002/cre2.510
6 SAPKOTA ET AL.
